Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial

Ann Neurol. 2000 May;47(5):686.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use*
  • Administration, Oral
  • Cytokines / biosynthesis
  • Double-Blind Method
  • Glatiramer Acetate
  • Humans
  • Interleukin-10 / biosynthesis*
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / metabolism
  • Peptides / pharmacology
  • Peptides / therapeutic use*

Substances

  • Adjuvants, Immunologic
  • Cytokines
  • Peptides
  • Interleukin-10
  • Glatiramer Acetate